Global Integrin Beta 8 Market, By Disease (Arteriovenous malformation and Arrhythmogenic right ventricular cardiomyopathy), By Application (Flow cytometry, CyTOF and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

This gene encodes a single-pass type I membrane protein with a VWFA domain and four cysteine-rich repeats that belongs to the integrin beta chain family. Integrins are the main metazoan receptors for cell adhesion to extracellular matrix proteins, and they also play a role in certain cell-cell adhesions, transmembrane connections to the cytoskeleton, and activation of several intracellular signaling cascades in vertebrates. The Integrin beta-8 component is a glycosylated polypeptide of 95 kDa that is similar to other beta chain integrins. It forms a heterodimer with the Alpha-V chain, which is found in mature synapses in mouse and rat brains. The ITGB8 gene (Integrin Subunit Beta 8) codes for a protein. Arteriovenous Malformation and Arrhythmogenic Right Ventricular Cardiomyopathy are two diseases that have been linked to ITGB8. ITGB5 is a significant paralog of this gene.

Growth in business operations by emerging and small sized players

Integrin beta 8 is gaining traction as a potential of various disease and cancer therapeutic target. During the forecast period, the Integrin beta 8 market is anticipated to be propelled by ongoing clinical trials and studies on Integrin beta 8 as a new cancer therapeutic option. The increasing focus on new research by government bodies and key companies is a fundamental driver driving global market expansion. The global Integrin beta 8 market is growing due to an increase in the number of people suffering from various health problem.

Source: Prophecy Market Insights

The global Integrin beta 8 market is segmented based on disease, application, and region.

On the basis of Disease, the global Integrin beta 8 market is segmented into Arteriovenous malformation and Arrhythmogenic right ventricular cardiomyopathy. Based on Application, the target market is segmented into Flow cytometry, CyTOF and Others.

Regional Insights:

On region the global Integrin beta 8 market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Report Scope:

Attribute	Details
Base year for estimation	2020
Forecast period	2020 – 2030
Market representation	Revenue in USD Million & CAGR from 2020 – 2030
Market Segmentation	By Disease- Arteriovenous malformation and Arrhythmogenic right ventricular cardiomyopathy By Application– Flow cytometry, CyTOF and Others
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the global Integrin beta 8 market report based on disease, application, and region.

Global Integrin Beta 8 Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating in the global Integrin beta 8 market includes Bio-Rad, LifeSpan Biosciences, OriGene, RanD system, Corbus Pharmaceuticals and Others.

 

• Bio-Rad.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• LifeSpan Biosciences
• RanD System
• OriGene
• Corbus Pharmaceuticals

“*” marked represents similar segmentation in other categories in the respective section

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
3. Market Purview
   • Executive Summary
   • Key Findings—Global Outlook for Integrin Beta 8 Strategies
     • Key Questions this Study will Answer
     • Market Snippet, By Disease
     • Market Snippet, By Application
     • Market Snippet, By Region
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Global Integrin Beta 8 Market, By Disease, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Arteriovenous malformation
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Arrhythmogenic right ventricular cardiomyopathy
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
6. Global Integrin Beta 8 Market, By Application, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Segment Trends
   • Flow cytometry
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • CyTOF
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
   • Others
     • Overview
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030

 

7. Global Integrin Beta 8 Market, By Region, 2020 – 2030, (US$ Mn)
   • Overview
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
     • Y-o-Y Growth Analysis (%), 2020 – 2030
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Mn), By Disease, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • U.S.
       • Canada
   • Europe
     • Market Size and Forecast (US$ Mn), By Disease, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • UK
       • France
       • Germany
       • Russia
       • Italy
       • Rest of Europe
   • Asia Pacific
     • Market Size and Forecast (US$ Mn), By Disease, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • India
       • Japan
       • South Korea
       • China
       • Rest of Asia Pacific
   • Latin America
     • Market Size and Forecast (US$ Mn), By Disease, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • Brazil
       • Mexico
       • Rest of Latin America
   • Middle East & Africa
     • Market Size and Forecast (US$ Mn), By Disease, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
     • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
       • GCC
       • Israel
       • South Africa
       • Rest of Middle East
8. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
9. Company Profiles

 

• BioRad.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• LifeSpan Biosciences
• RanD System
• OriGene
• Corbus Pharmaceuticals

The Last Word

• • Future Impact
  • About Us
  • Contact